NDC 47335-177
Ilumya 100 mg per 1 mL injection, solution
On the label: Caraco Pharmaceutical Laboratories, Ltd..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Samsung Biologics Co., Ltd. | Incheon, South Korea | Makes the active ingredient | Problems found, fixed voluntarilySep 1, 2023 · 3 inspections |
| Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Schuetzenstrasse) | Ravensburg, Germany | Makes it | Problems found, fixed voluntarilyJul 13, 2022 · 10 inspections |
| Tjoapack Netherlands BV | Etten-Leur, Netherlands | Packages it | Problems found, fixed voluntarilyFeb 13, 2025 · 2 inspections |
| Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen) | Ravensburg, Germany | Packages it | Problems found, fixed voluntarilyJul 21, 2023 · 8 inspections |
Product details
- Generic drug
- Tildrakizumab: every company that makes it
- Form
- injection, solution, subcutaneous
- Strength
- 100 mg per 1 mL
- Approval
- BLA BLA761067
- On the market since
- Aug 6, 2018
- Package NDCs
47335-177-0147335-177-1047335-177-9547335-177-96- Official label
- DailyMed (National Library of Medicine), updated Nov 2, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?